101 related articles for article (PubMed ID: 16604825)
41. Sarpogrelate diminishes changes in energy stores and ultrastructure of the ischemic-reperfused rat heart.
Temsah RM; Kumamoto H; Takeda N; Dhalla NS
Can J Physiol Pharmacol; 2001 Sep; 79(9):761-7. PubMed ID: 11599776
[TBL] [Abstract][Full Text] [Related]
42. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.
Hara H; Osakabe M; Kitajima A; Tamao Y; Kikumoto R
Thromb Haemost; 1991 Apr; 65(4):415-20. PubMed ID: 2057925
[TBL] [Abstract][Full Text] [Related]
43. Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency.
Sharma SK; Del Rizzo DF; Zahradka P; Bhangu SK; Werner JP; Kumamoto H; Takeda N; Dhalla NS
Ann Thorac Surg; 2001 Jun; 71(6):1856-64; discussion 1865. PubMed ID: 11426759
[TBL] [Abstract][Full Text] [Related]
44. Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus.
Shouzu A; Nomura S; Hayakawa T; Omoto S; Shimizu H; Miyake Y; Yonemoto T; Fukuhara S; Iwasaka T; Nishikawa M; Inada M
Clin Appl Thromb Hemost; 2000 Jul; 6(3):139-43. PubMed ID: 10898273
[TBL] [Abstract][Full Text] [Related]
45. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
[TBL] [Abstract][Full Text] [Related]
46. 5-HT2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury.
Rajesh KG; Suzuki R; Maeda H; Murio Y; Sasaguri S
Life Sci; 2006 Sep; 79(18):1749-55. PubMed ID: 16876202
[TBL] [Abstract][Full Text] [Related]
47. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
[TBL] [Abstract][Full Text] [Related]
48. Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits.
Takano S
Arch Int Pharmacodyn Ther; 1995; 330(3):297-308. PubMed ID: 8836449
[TBL] [Abstract][Full Text] [Related]
49. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
Nishio H; Inoue A; Nakata Y
Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
[TBL] [Abstract][Full Text] [Related]
50. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
51. Effects of sarpogrelate on blood viscosity.
Yum KS; Kang SG; Lee JW; Cho YI
Microvasc Res; 2023 Jan; 145():104439. PubMed ID: 36126755
[TBL] [Abstract][Full Text] [Related]
52. The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus.
Pietraszek MH; Takada Y; Taminato A; Yoshimi T; Watanabe I; Takada A
Thromb Res; 1993 Apr; 70(2):131-8. PubMed ID: 8322284
[TBL] [Abstract][Full Text] [Related]
53. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats.
Sasaki M; Obata H; Kawahara K; Saito S; Goto F
Pain; 2006 May; 122(1-2):130-6. PubMed ID: 16527395
[TBL] [Abstract][Full Text] [Related]
54. Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.
Kokubu N; Tsuchihashi K; Yuda S; Hase M; Eguchi M; Wakabayashi T; Hashimoto A; Nakata T; Miura T; Ura N; Nagao K; Tsuzuki M; Wakabayashi C; Shimamoto K
Circ J; 2006 Nov; 70(11):1451-6. PubMed ID: 17062970
[TBL] [Abstract][Full Text] [Related]
55. Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model.
Bledsoe SL; Barr JC; Fitzgerald RT; Brown AT; Faas FH; Eidt JF; Moursi MM
Vasc Endovascular Surg; 2006; 40(1):49-57. PubMed ID: 16456606
[TBL] [Abstract][Full Text] [Related]
56. Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats.
Nishiyama T
Eur J Pharmacol; 2009 Jul; 614(1-3):122-7. PubMed ID: 19318092
[TBL] [Abstract][Full Text] [Related]
57. Sarpogrelate inhibits the expression of ICAM-1 and monocyte-endothelial adhesion induced by high glucose in human endothelial cells.
Su Y; Mao N; Li M; Dong X; Lin FZ; Xu Y; Li YB
Mol Cell Biochem; 2013 Jan; 373(1-2):195-9. PubMed ID: 23111892
[TBL] [Abstract][Full Text] [Related]
58. 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Blood Coagul Fibrinolysis; 2005 Sep; 16(6):423-8. PubMed ID: 16093733
[TBL] [Abstract][Full Text] [Related]
59. Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Vascul Pharmacol; 2004 Feb; 41(1):7-13. PubMed ID: 15135326
[TBL] [Abstract][Full Text] [Related]
60. [Pharmacological analysis of inhibitory effect of sarpogrelate hydrochloride on human radial artery contraction].
Adachi A
Hokkaido Igaku Zasshi; 2002 Jan; 77(1):57-62. PubMed ID: 11868372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
